Subscribe To
Eterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics
Acquisition includes Exacis’ entire pipeline of engineered cell therapy programs for hematologic and solid tumors CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) — Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the […] The post Eterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics...
Read More
Content Topics
Eterna
Therapeutics
Acquires
Allogeneic
Immuno
Oncology
Immuno oncology
Platform
Exacis
Biotherapeutics
Forex
Posted: May 2 2023, 11:30
Author Name: forextv
Views: 102061